Description

({3-[(4-Amino-6,7-Dimethoxy-2-Quinazolinyl)(Methyl)Amino]Propyl}Amino)(2-Furyl)Methanol CAS NO 98902-36-4 is a sophisticated quinazoline derivative, a key intermediate in the synthesis of advanced pharmaceutical compounds. Its molecular structure is designed to act as a critical building block for active pharmaceutical ingredients (APIs) targeting specific biological pathways. This high-purity intermediate is essential for research institutions and pharmaceutical manufacturers engaged in the development of novel therapeutics, particularly in oncology and cardiovascular disease research. We provide this compound with a focus on batch-to-batch consistency and supply chain reliability to support critical R&D and scale-up processes.

Application

• Pharmaceutical Intermediate: Primary use as a key synthetic precursor in the manufacture of complex Active Pharmaceutical Ingredients (APIs).
• Research & Development: Serves as a critical reagent in medicinal chemistry for the discovery and optimization of new drug candidates, particularly kinase inhibitors.
• Chemical Synthesis: Used in advanced organic synthesis to construct complex heterocyclic frameworks found in many modern therapeutics.
• Reference Standard: Supplied as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
• Biochemical Research: Employed in biochemical assays and pharmacological studies to investigate enzyme interactions and cellular signaling pathways.

Basic Information

Product Name	({3-[(4-Amino-6,7-Dimethoxy-2-Quinazolinyl)(Methyl)Amino]Propyl}Amino)(2-Furyl)Methanol
CAS No.	98902-36-4
Molecular Formula	C19H25N5O4
Molecular Weight	387.43 g/mol
Synonyms	N-[3-[[(2-Furyl)hydroxymethyl]amino]propyl]-N-methyl-6,7-dimethoxy-2-quinazolinamine; 4-Amino-6,7-dimethoxy-N-methyl-N-[3-[[(2-furanylmethyl)hydroxyamino]propyl]-2-quinazolinamine; 2-Quinazolinamine, 4-amino-6,7-dimethoxy-N-methyl-N-[3-[[(2-furanylmethyl)hydroxyamino]propyl]-; ({3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]propyl}amino)(2-furyl)methanol; Quinazoline derivative intermediate 98902-36-4.
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to stringent quality protocols. Every batch is subjected to comprehensive analytical testing, including HPLC for purity and identity confirmation via IR and NMR. We ensure compliance with relevant internal specifications designed for pharmaceutical R&D use. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting critical quality attributes. Our commitment to traceability and documentation supports your regulatory and quality assurance requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere packaging.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.